RIVM launches study on long-term effectiveness of COVID-19 vaccines RIVM is launching an extensive study today to research the long-term effectiveness of the various COVID-19 vaccines in the Netherlands.
Third wave shows major surge in hospital admissions in younger age groups In the week of 28 April to 4 May, there were 8% fewer new hospital admissions of people with COVID-19 compared to the week before.
First people with medical risk invited for vaccination People with a medical condition who are eligible for an annual seasonal flu vaccination will be invited for a COVID-19 vaccination in phases, starting on Thursday, 6 May.
People born in 1962 invited for COVID-19 vaccination The first people born in 1962 will be receiving an invitation for a COVID-19 vaccination this week. This group involves people who will be turning 59 this year.
Dutch experts on climate change adaptation join forces Fourteen Dutch knowledge institutes have joined forces to provide practical, demand-driven policy advice based on climate change adaptation.
Substances of very high concern hamper recycling Substances of very high concern (SVHC) can hamper the safe recycling of waste streams in the Netherlands. These substances occur in a wide range of waste streams.
Chemical legislation REACHes out to bio-based economy European REACH regulation on chemicals can provide benefits to companies that make or import bio-based substances.
Greenhouse Emission model suited for the authorisation of plant protection products Residues of plant protection products used in greenhouses may enter surface water upon discharge of nutrient solution and affect surface water organisms.